ArticleEndocrine2026
Radiomics-Based machine learning for preoperative prediction of Large-Number central lymph node metastasis in papillary thyroid carcinoma.
Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeThis study aimed to develop interpretable machine learning (ML) models integrating preoperative clinical, ultrasound (US), and radiomic features for predicting large-number central lymph node metastasis (CLNM) in papillary thyroid carcinoma (PTC).
methodsThis retrospective study analyzed 1,400 PTC patients undergoing thyroidectomy with central lymph node dissection (CLND) between January 2018 and May 2025. Stratified by large-number CLNM status, patients were randomized into training (n = 980) and test (n = 420) cohorts. Key predictors were identified via Least Absolute Shrinkage and Selection Operator (LASSO) and logistic regression. Six ML algorithms were trained using Synthetic Minority Over-sampling Technique (SMOTE) for class imbalance. Performance evaluation used the area under the receiver operating characteristic curve (ROC-AUC), precision-recall curve AUC (PR-AUC), and decision curve analysis (DCA). Optimal model interpretation used Shapley Additive Explanations (SHAP).
resultsLarge-number CLNM occurred in 92 (6.6%) patients. Predictors included clinical/US features (age, tumor size, suspicious nodes, tracheal capsular invasion) and a 7-feature LASSO-selected radiomics signature. The integrated model achieved ROC-AUCs of 0.880 (95% confidence interval: 0.841–0.912; training) and 0.827 (0.738–0.901; testing), significantly outperforming submodels in PR-AUC (p < 0.05). SHAP quantified feature contributions.
conclusionThis ML model preoperatively identifies PTC patients at high risk for large-number CLNM, offering potential to personalize treatment decisions and reduce unnecessary surgery.
Indexed as
Identifiers
41803556What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.